Document Detail


Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats.
MedLine Citation:
PMID:  25310909     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The present study was designed to investigate whether oxymatrine could attenuate isoproterenol-induced heart failure via regulation of asymmetric dimethylarginine (ADMA) metabolism in rats. Heart failure model was established by once daily subcutaneous injection of isoproterenol (5mg/kg/d) to rats for 7 days. Simultaneously, oral administration of oxymatrine (25, 50 and 100mg/kg/d, respectively) was started from day 1 to day 7, or with vehicle as corresponding controls. After continuous preventive administration of oxymatrine for 7 days, significant isoproterenol-induced heart failure characterized by hypertrophy and dysfunction of left ventricular, and elevation of brain natruretic peptide (BNP, a heart failure biomarker) and cardiac troponin I (cTn-I, a cardiac injury biomarker) was observed. Preventive oxymatrine significantly ameliorated the cardiac hypertrophy, improved the left ventricular dysfunction and reduced the increased BNP and cTn-I in serum of isoproterenol-treated rats. And obvious changes with decrease of systolic blood pressure and increase of heart rate were present in isoproterenol group and normalized by oxymatrine. Besides, prevention with oxymatrine significantly up-regulated the dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression, which was followed by decreased serum ADMA, but it had no effect on protein arginine methyltransferase1 (PRMT1) expression that is up-regulated in isoproterenol-induced heart failure rats. These results manifested that preventive oxymatrine could ameliorate the hypertrophy and dysfunction of left ventricle of rats with heart failure, which is attributed to modulation of DDAH/ADMA metabolism pathway by oxymatrine.
Authors:
Wei Zhang; Jian Zhang; Yansheng Kang; Jingjing Liu; Xiaoqing Wang; Qingbin Xu; Yilei Wang; Xiaoya Xu; Guidong Dai
Related Documents :
25226339 - Correlation between trans and intra-thoracic impedance and conductance in patients with...
25196119 - Radioiodinated acebutolol as a new highly selective radiotracer for myocardial perfusio...
20505799 - The effect of insulin on the heart: part 2: effects on function during and post myocard...
22405659 - Cardiac magnetic resonance imaging for stage b heart failure.
941949 - Placental lesions in experimental toxemia in the rabbit.
25456699 - Disrupted right ventricular force-frequency relationships in adults operated for ventri...
17275699 - Extent of right and left ventricular focal wall-motion abnormalities in differentiating...
3218899 - The finnish sauna and cardiovascular diseases.
16610339 - History of arrhythmias.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-10
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-14     Completed Date:  -     Revised Date:  2014-10-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier B.V.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt ...
Next Document:  Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic ox...